Results 91 to 100 of about 3,293,378 (262)

Effect of Missed Doses on the Therapeutic Effect of Methotrexate for Rheumatoid Arthritis: A Pharmacokinetic Modeling Study

open access: yesOpen Access Rheumatology: Research and Reviews, 2021
Alan Morrison,1 Melissa E Stauffer,1,2 Anna S Kaufman1 1ScribCo, Albrightsville, PA, USA; 2Scientific Editing Solutions, Walworth, WI, USACorrespondence: Alan MorrisonScribCo, 111 Gower Road, Albrightsville, PA, 18210, USATel +1 610 389-0843Email ...
Morrison A, Stauffer ME, Kaufman AS
doaj  

Changing trends in drug overdose mortality in Spain, 2001–2022

open access: yesAddiction, Volume 121, Issue 2, Page 261-272, February 2026.
Abstract Aim To measure the evolution of drug overdose mortality in Spain between 2001 and 2022. Design, Setting, Participants A repeated cross‐sectional observational study using nationwide mortality data from Spain, 2001–2022, among individuals aged 15–64 years.
Florencia Giné   +6 more
wiley   +1 more source

Use of healthcare administrative claims data in observational studies of antirheumatic drug effects on pregnancy outcomes: A scoping review.

open access: yesPLoS ONE
The safety of antirheumatic drugs in pregnancy and their impact on maternal and neonatal outcomes are understudied. Despite pregnant individuals being excluded from clinical trials, their continued use of medications raises the importance of addressing ...
Shenthuraan Tharmarajah   +7 more
doaj   +1 more source

Comparative effectiveness of sodium‐glucose cotransporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists for incident dementia: A retrospective multicohort study

open access: yesDiabetes, Obesity and Metabolism, Volume 28, Issue 2, Page 1443-1452, February 2026.
Abstract Objective This study provides real‐world evidence on the comparative effectiveness of glucagon‐like peptide‐1 receptor agonists (GLP‐1 RAs) and sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) regarding the risk of incident dementia in adults with type 2 diabetes mellitus (T2DM).
Filippos Anagnostakis   +4 more
wiley   +1 more source

The role of disease-modifying antirheumatic drugs in the implementation of the «treat-to-target» strategy for rheumatoid arthritis

open access: yesКаразінський імунологічний журнал
Background. Rheumatoid arthritis is a chronic systemic autoimmune disease that remains one of the leading causes of disability worldwide. Effective management of this condition requires a modern approach focused on the early achievement of therapeutic ...
F.V. Hladkykh
doaj   +1 more source

FRI0221 Does seropositivity influence differentially drug discontinuation of biologic antirheumatic agents with non-anti-tnf mode of action? [PDF]

open access: bronze, 2017
Axel Finckh   +16 more
openalex   +1 more source

Tofacitinib‐Induced Weight Gain in Context: comment on the article by Wollenhaupt et al.

open access: yes
ACR Open Rheumatology, Volume 8, Issue 2, February 2026.
Andriko Palmowski   +4 more
wiley   +1 more source

Magnetic resonance imaging in patients with rheumatoid arthritis with complete remission treated with disease-modifying antirheumatic drugs or anti-tumour necrosis factor α agents [PDF]

open access: bronze, 2006
Marco Ulises Martínez‐Martínez   +5 more
openalex   +1 more source

Home - About - Disclaimer - Privacy